Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.26 billion. The enterprise value is $1.40 billion.
| Market Cap | 1.26B |
| Enterprise Value | 1.40B |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 45.92 million shares outstanding. The number of shares has decreased by -1.48% in one year.
| Shares Outstanding | 45.92M |
| Shares Change (YoY) | -1.48% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 101.68% |
| Float | 45.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.17 |
| PS Ratio | 1.10 |
| Forward PS | 1.16 |
| PB Ratio | 1.06 |
| P/FCF Ratio | 9.99 |
| PEG Ratio | 2.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.99, with an EV/FCF ratio of 11.07.
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | 22.99 |
| EV / EBIT | n/a |
| EV / FCF | 11.07 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.52 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 9.95 |
| Debt / FCF | 4.79 |
| Interest Coverage | 2.36 |
Financial Efficiency
Return on equity (ROE) is -1.70% and return on invested capital (ROIC) is -1.95%.
| Return on Equity (ROE) | -1.70% |
| Return on Assets (ROA) | -0.90% |
| Return on Capital (ROIC) | -1.95% |
| Revenue Per Employee | $314,277 |
| Profits Per Employee | -$5,581 |
| Employee Count | 3,650 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 5.05 |
Taxes
In the past 12 months, Omnicell has paid $263,000 in taxes.
| Income Tax | 263,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.03% in the last 52 weeks. The beta is 0.76, so Omnicell's price volatility has been lower than the market average.
| Beta (1Y) | 0.76 |
| 52-Week Price Change | -56.03% |
| 50-Day Moving Average | 27.67 |
| 200-Day Moving Average | 40.60 |
| Relative Strength Index (RSI) | 47.29 |
| Average Volume (30 Days) | 567,825 |
Short Selling Information
The latest short interest is 2.32 million, so 5.06% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.29M |
| Short % of Shares Out | 5.06% |
| Short % of Float | 5.14% |
| Short Ratio (days to cover) | 4.20 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.15 billion and -$20.37 million in losses. Loss per share was -$0.45.
| Revenue | 1.15B |
| Gross Profit | 496.84M |
| Operating Income | -34.87M |
| Pretax Income | -20.11M |
| Net Income | -20.37M |
| EBITDA | 60.69M |
| EBIT | -34.87M |
| Loss Per Share | -$0.45 |
Balance Sheet
The company has $467.97 million in cash and $603.57 million in debt, giving a net cash position of -$135.60 million or -$2.95 per share.
| Cash & Cash Equivalents | 467.97M |
| Total Debt | 603.57M |
| Net Cash | -135.60M |
| Net Cash Per Share | -$2.95 |
| Equity / Book Value | 1.19B |
| Book Value Per Share | 25.89 |
| Working Capital | 559.78M |
Cash Flow
In the last 12 months, operating cash flow was $181.09 million and capital expenditures -$55.02 million, giving a free cash flow of $126.08 million.
| Operating Cash Flow | 181.09M |
| Capital Expenditures | -55.02M |
| Free Cash Flow | 126.08M |
| FCF Per Share | $2.79 |
Margins
Gross margin is 43.31%, with operating and profit margins of -3.04% and -1.78%.
| Gross Margin | 43.31% |
| Operating Margin | -3.04% |
| Pretax Margin | -1.75% |
| Profit Margin | -1.78% |
| EBITDA Margin | 5.29% |
| EBIT Margin | -3.04% |
| FCF Margin | 10.99% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.48% |
| Shareholder Yield | 1.48% |
| Earnings Yield | -1.62% |
| FCF Yield | 10.01% |
Analyst Forecast
The average price target for Omnicell is $43.25, which is 57.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $43.25 |
| Price Target Difference | 57.67% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 10.86% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 1.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.73 |
| Piotroski F-Score | 4 |